Kinase Inhibitor Screening Displayed ALK as a Possible Therapeutic Biomarker for Gastric Cancer is a research paper published in Pharmaceutics (2022). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Brazilian funding agencies
Grant: 404213/2021-9
Brazilian funding agencies
Grant: 18/2021
Brazilian funding agencies
Grant: 403493/2021-8
National Council for Scientific and Technological Development
Grant: Pq scholarships
PROPESP/UFPA
Brazilian funding agencies
FWCI
0.55
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals